To translate these findings clinically, additional work is required to determine the best approach for combining NOX4 inhibition with other types of therapy, examining the effect of these treatments on tumor progression in more detail (for example, effect on metastatic spread), and using spontaneous/orthotopic murine model systems. This evidence concerns the gene NOX4 and neoplasm.